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Abstract 
Background: Cache Valley virus (CVV; Bunyavirales, Peribunyaviridae) is a mosquito‑borne arbovirus endemic in North 
America. Although severe diseases are mainly observed in pregnant ruminants, CVV has also been recognized as a 
zoonotic pathogen that can cause fatal encephalitis in humans. Human exposures to CVV and its related subtypes 
occur frequently under different ecological conditions in the New World; however, neurotropic disease is rarely 
reported. High prevalence rates of neutralizing antibodies have been detected among residents in several Latin 
American cities. However, zoophilic mosquito species involved in the enzootic transmission are unlikely to be respon‑
sible for the transmission leading to human exposures to CVV. Mechanisms that lead to frequent human exposures to 
CVV remain largely unknown. In this study, competence of two anthropophilic mosquitoes, Aedes albopictus and Ae. 
aegypti, for CVV was determined using per os infection to determine if these species could play a role in the transmis‑
sion of CVV in the domestic and peridomestic settings of urban and suburban areas.
Results: Aedes albopictus were highly susceptible to CVV whereas infection of Ae. aegypti occurred at a significantly 
lower frequency. Whilst the dissemination rates of CVV were comparable in the two species, the relatively long period 
to attain maximal infectious titer in Ae. aegypti demonstrated a significant difference in the replication kinetics of CVV 
in these species. Detection of viral RNA in saliva suggests that both Ae. albopictus and Ae. aegypti are competent vec‑
tors for CVV under laboratory conditions.
Conclusions: Differential susceptibility to CVV was observed in Ae. albopictus and Ae. aegypti, reflecting their rela‑
tively different capacities for vectoring CVV in nature. The high susceptibility of Ae. albopictus to CVV observed in this 
study suggests its potential role as an efficient vector for CVV. Complemented by the reports of multiple CVV isolates 
derived from Ae. albopictus, our finding provides the basis for how the dispersal of Ae. albopictus across the New World 
may have a significant impact on the transmission and ecology of CVV.
Keywords: Cache Valley virus, Aedes albopictus, Aedes aegypti, Competent vectors
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Open Access
Parasites & Vectors
*Correspondence:  yshuang1985@bri.ksu.edu; dlvanlan@vet.k‑state.edu 
1 Department of Diagnostic Medicine/Pathobiology, College of Veterinary 
Medicine, Kansas State University, Manhattan, KS 66506, USA
2 Biosecurity Research Institute, Kansas State University, Manhattan,  
KS 66506, USA
Full list of author information is available at the end of the article
Page 2 of 6Ayers et al. Parasites Vectors          (2019) 12:384 
Background
Cache Valley virus (CVV) is a mosquito-borne arbovirus 
(genus Orthobunyavirus, family Peribunyaviridae). The 
virus was first isolated from Culiseta inornata in Utah, 
USA, in 1956 [1], and is now regarded as the most widely 
distributed member within the Bunyamwera serogroup 
in the New World [2]. CVV has been found extensively 
throughout North America with several known regional 
subtypes, including Maguari virus, Xingu virus, and Fort 
Sherman virus circulating in Latin America [3–6]. His-
torically, CVV has been regarded as an important agricul-
tural pathogen associated with embryonic lethality and 
abortions in ruminants. Infections in humans are largely 
asymptomatic or associated with mild febrile diseases. 
Although the association between CVV infection and 
neurological human diseases was first suggested in 1995, 
the pathogenicity of CVV in humans was not recognized 
until several cases of neurotropic diseases were directly 
attributed to CVV infection [7]. As an endemic pathogen 
in the Americas, serological surveys have demonstrated 
that humans in the New World can be exposed to CVV 
under various ecological conditions. The intensive trans-
mission of CVV on the Eastern Shore of Maryland and 
Virginia, USA, coincided with the high seroprevalence 
rate among residents of Chincoteague Island, where salt-
water marsh is the predominant mosquito habitat [8, 9]. 
Based on serology, CVV was demonstrated to occur in 
the urban and suburban environments in Latin America, 
where the majority of mosquito infestation is associated 
with container-inhabiting mosquitoes, especially Aedes 
aegypti and Ae. albopictus [10–12]. In the capital city of 
Mérida in the Yucatan State, Mexico, neutralizing anti-
bodies against CVV can be found in 18% of individuals 
with febrile illness [9]. Similarly, the silent transmission 
of CVV also led to up to 8% seroprevalence rate among 
residents of the Córodoba Province, Argentina [13]. 
Despite the evidence suggesting frequent transmission of 
CVV to humans across the Americas, very little is known 
about the specific vectors responsible for transmission 
to humans. A major limitation in our understanding of 
mechanisms responsible for the high prevalence rates of 
neutralizing human antibodies in the urban and subur-
ban areas is the lack of knowledge on the vector compe-
tence of domestic and peridomestic mosquitoes for CVV.
CVV has been isolated from over 30 species of mos-
quitoes [14]. However, the majority of competent vectors 
for CVV are not domestic or peridomestic species that 
can efficiently spread arboviruses among humans in the 
cities. For instance, the two endemic vectors for CVV, 
Anopheles quadrimaculatus and Culiseta inornata are 
not common in urban and suburban areas [15, 16]. Other 
competent species, including Ae. taeniorhynchus and Ae. 
sollicitans, are normally found in saltwater marshes [17, 
18]. As a potential bridge vector that is known to sup-
port the transmission of CVV, the distribution of Culex 
tarsalis is rare under urban landscapes and precludes its 
potential role as a domestic or peridomestic vector [19, 
20]. Domestic Culex spp. mosquitoes which contributed 
to the isolation of CVV in nature are known to be refrac-
tory through per os infection, suggesting that CVV in the 
urban and suburban areas are likely to be vectored by 
other mammophillic species [20].
Isolation of CVV from Ae. albopictus and Ae. japoni-
cus is suggestive of the potential involvement of domes-
tic and peridomestic Aedes species mosquitoes in the 
transmission of CVV from animals to humans [21, 22]. 
In the northeastern USA, both species have been found 
to be mammophillic, feeding on humans and white-tailed 
deer, a major amplification host of CVV [23–25]. With 
the exception of Ae. japonicus, which has previously been 
investigated for its competence for CVV under labora-
tory conditions, the vectorial efficiency of domestic and 
peridomestic Aedes species for CVV remains largely 
undetermined [26]. In this study, Ae. albopictus and Ae. 
aegypti were orally challenged with CVV to investigate 
the dynamics of infection, dissemination and transmis-
sion. The results demonstrate that Ae. albopictus can be 
an efficient vector for CVV and provide the basis of our 
knowledge in the transmission of CVV to humans in the 
urban and suburban environment.
Methods
Virus and per os challenge of mosquitoes
The prototype CVV 6V633 strain was used in all oral 
challenge experiments. Virus stocks were propagated 
and titered in African green monkey kidney Vero76 
cells in Leibovitz’s L-15 media (Thermo Fisher Scien-
tific, Waltham, MA, USA) supplemented with 10% fetal 
bovine serum (Thermo Fisher Scientific, Waltham, MA, 
USA), 10% tryptose phosphate broth (Sigma-Aldrich, 
St. Louis, MO, USA), penicillin/streptomycin (Thermo 
Fisher Scientific, Waltham, MA, USA) and l-glutamine 
(Thermo Fisher Scientific, Waltham, MA, USA), as pre-
viously described [20]. Frozen stocks at 7.95 log median 
tissue culture infectious dose  (TCID50)/ml were thawed 
at 37 °C and mixed with an equal volume of defibrinated 
sheep blood (Colorado Serum Company, Denver, CO, 
USA) to generate infectious blood meals.
Per os infection of mosquitoes was performed with 
7-to-10-day-old female Ae. aegypti Higgs white-eye strain 
(F > 20), and with Ae. albopictus  (F4), which were derived 
from eggs collected from the city of Trenton, Mercer 
County, NJ, USA, in July 2016. In each of the three inde-
pendent repeats of oral challenge experiments, 2 cartons 
of 100 mosquitoes each were orally exposed to viremic 
blood meals containing CVV. Mosquitoes were deprived 
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of sucrose for 24 h prior to infection. Infectious blood 
meals were administered through a Hemotek mem-
brane feeding system (Discovery Workshop, Lancashire, 
United Kingdom) using previously described techniques 
[27]. Engorged mosquitoes were cold-anesthetized, col-
lected, and maintained at 28 °C for 14 days as previously 
described [10]. Up to three engorged mosquitoes at the 
end of each oral challenge experiment were collected and 
titrated to confirm the ingestion of infectious viruses. 
Orally challenged mosquitoes were mechanically aspi-
rated at 7 and 14 days post-infection (dpi) for the assess-
ment of infection status. Forced salivation of immobilized 
mosquitoes was also performed at 14 dpi to determine 
the incidence of transmission [20].
Detection of infectious virus
The dynamics of infection and dissemination was deter-
mined based on the detection of infectious viruses in 
homogenized tissues dissected from mosquitoes col-
lected at 7 and 14 dpi. Whole mosquitoes were also col-
lected without dissection to assess the growth kinetics 
of CVV in infected mosquitoes. Samples were homog-
enized at 26 Hz for 4 min and titrated using Vero76 cells. 
All concentrations of infectious viruses are calculated as 
 TCID50/ml [5]. Reverse-transcriptase nested polymer-
ase chain reactions were performed to detect viral RNA 
present in mosquito saliva. Viral RNA was extracted with 
QIAamp Viral RNA Mini Kit (Qiagen, Valencia, CA, 
USA), reverse transcribed with Superscript III reverse 
transcriptase (Invitrogen, Carlsbad, CA, USA) and ampli-
fied using Platinum Taq DNA polymerase (Thermo Fisher 
Scientific, Waltham, MA, USA) as previously described 
[20]. A gene-specific primer (CV-Mex-R: 5′-GAC GTC 
TGT TAA GAA GCA AGT TGA GTT T-3′) was used 
for cDNA synthesis followed by the amplification using 
nested PCR (first primer set: CV-Mex-F: 5′-GCA CTC 
TGG CAG GCA GGA-3′ and CV-Mex-R: 5′-GAC GTC 
TGT TAA GAA GCA AGT TGA GTT T-3′; second 
primer set: CV-G1-F: 5′-CCA ATG CAA TTC AGG 
GCA GT-3′ and CV-G1-R: 5′-TGA GTC ACC ACA TGC 
TGT AAG GT-3′). All amplicons were separated and vis-
ualized by electrophoresis on 4% agarose gels at 125V for 
40 min.
Statistical analysis
Infection, dissemination, and transmission rates of 
CVV were calculated based on the criteria previously 
described [20]. Briefly, infection rates of CVV were cal-
culated based on the incidence for the positive detec-
tion of infectious viruses in both dissected mosquitoes 
and whole mosquito carcasses. Dissemination rates were 
determined based on the percentage of positive virus 
isolation from the secondary tissues of dissected mos-
quitoes that were infected with CVV. Differences in the 
percentage of infection, dissemination, and transmission 
were determined using Chi-square test or Fisher’s exact 
test, depending on the sample sizes in the contingency 
tables. Titers of infected mosquitoes were compared with 
Mann-Whitney rank sum test between two groups when 
normal distribution is not observed or Student’s t-test 
when infectious titers follow normal distribution. All 
statistical analyses were conducted using GraphPad (San 
Diego, CA, USA), SigmaPlot (San Jose, CA, USA), and 
Excel software (Redmond, WA, USA).
Results
Differential susceptibility to CVV between Ae. albopictus 
and Ae. aegypti
Oral challenge with CVV led to the establishment of 
infection in both Ae. albopictus and Ae. aegypti. As sum-
marized in Table 1, the significantly higher infection rates 
were observed in Ae. albopictus at both 7 dpi [Ae. albop-
ictus: 69.2% (45/65) vs Ae. aegypti:15.2% (10/66), Chi-
square test: χ2 = 37.13, df = 1, P < 0.001] and 14 dpi [Ae. 
Table 1 Average titers of engorged mosquitoes, infection, dissemination, and transmission rates in mosquitoes challenged with CVV
a The infection rate of CVV at 7 and 14 dpi was determined by the isolation of infectious viruses in tissues of dissected mosquitoes or carcasses of whole mosquitoes 
using Vero76 cells
b Significant differences between Ae. albopictus and Ae. aegypti were detected using Chi-square test
c The dissemination rate of CVV at 7 and 14 dpi was calculated based on the detection of infectious viruses in secondary tissues (head, wings and legs) of dissected 
mosquitoes, which were infected with CVV
d The transmission rate of CVV was determined by the incidence of positive detection of viral RNA among saliva of infected mosquitoes using nested RT-PCR
Mosquito species 0 dpi 7 dpi 14 dpi
Average titers 
of engorged 
mosquitoes 
 (logTCID50/ml)
Infection rate (%)ab Dissemination rate 
(%)c
Infection rate (%)ab Dissemination rate 
(%)c
Transmission rate (%)d
Ae. albopictus 3.7 ± 0.6 (n = 11) 69.2 (45/65) 83.3 (25/30) 56.5 (26/46) 100.0 (12/12) 29.6 (8/27)
Ae. aegypti 4.0 ± 0.8 (n=18) 15.2 (10/66) 100 (4/4) 11.0 (9/82) 100 (5/5) 30.0 (3/10)
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albopictus: 56.5% (26/46) vs Ae. aegypti: 11.0% (9/82), 
Chi-square test: χ2 = 28.52, df = 1, P < 0.001], indicating 
higher susceptibility of Ae. albopictus to CVV than Ae. 
aegypti. Consistent with the differences in susceptibility, 
Ae. albopictus supported more rapid replication of CVV 
as demonstrated by significantly higher average titers of 
whole mosquitoes collected at 7 dpi [Ae. albopictus (aver-
age titer ± standard deviation): 5.0 ± 2.2  logTCID50/ml vs 
Ae. aegypti (average titer ± standard deviation): 3.1 ± 2.7 
 logTCID50/ml; t-test: t = 1.713, df = 19; P = 0.02] (Fig. 1). 
Although there was no significant difference in titers of 
infected mosquitoes at 14 dpi [Ae. albopictus (median 
titer): 6.0  logTCID50/ml vs Ae. aegypti (median titer): 5.5 
 logTCID50/ml; Mann–Whitney test: U = 22, P = 0.55].
Whilst significant differences in susceptibility and 
replication kinetics were observed, the incidence of dis-
seminated infection was indistinguishable at 7 dpi [Ae. 
albopictus: 83.3% (25/30) vs Ae. aegypti: 100% (4/4), Fish-
er’s exact test: χ2 = 37.13, df = 1, P = 1.00] and 14 dpi [Ae. 
albopictus: 100% (12/12) vs Ae. aegypti: 100% (5/5)]. Our 
results indicate that infection with CVV can be estab-
lished in both Ae. albopictus and Ae. aegypti through the 
ingestion of viremic blood meals.
Domestic and peridomestic Aedes species mosquitoes are 
competent vectors for CVV
At 14 dpi, viral RNA was detected in saliva collected from 
29.6% (8/27) of infected Ae. albopictus. Similarly, 30.0% 
(3/10) of infected Ae. aegypti also showed a positive 
detection of viral RNA in the saliva. The presence of viral 
RNA following oral exposure to CVV indicates that both 
species are competent vectors for CVV. Although the 
transmission rate for both species was approximately 
30%, the higher infection rates for Ae. albopictus, as com-
pared to Ae. aegypti, indicate that there could potentially 
be more infected Ae. albopictus involved in the overall 
transmission of CVV.
Discussion
The results of our study demonstrated that both Ae. 
albopictus and Ae. aegypti are susceptible to CVV. The 
differential susceptibility suggests there can potentially be 
a difference in the likelihood of the two species in vector-
ing CVV to humans in nature, especially in the southern 
USA and Latin America. The relatively high competence 
of Ae. albopictus demonstrated in this study, and large 
numbers of isolates recovered from nature, suggest that 
this species may be actively involved in the enzootic and 
epizootic transmission of CVV in regions where viremic 
vertebrate hosts and humans coexist [22]. Interestingly, 
detection of CVV in Ae. albopictus coincides with the 
dispersal of lineage 2 viruses from southern Mexico to 
the northeastern USA. All CVV isolates from Ae. albop-
ictus in northeastern USA have also been demonstrated 
to cluster under the same lineage 2. These findings war-
rant further investigation whether the species also con-
tributed to the emergence of the new genetic lineage in 
North and Central America [22, 28]. As the distribution 
Fig. 1 Infectious titers of whole mosquitoes infected with CVV at 7 and 14 dpi. Titers of individual infected Ae. aegypti and Ae. albopictus are shown 
in circle and triangle, respectively. The grey solid line represents the average titer of each species at 7 and 14 dpi
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of Ae. aegypti in North America has just exceeded 33°N 
latitude between 2011 and 2014 and the introduction 
of Ae. albopictus did not take place until the 1980s, the 
high prevalence of neutralizing antibodies against CVV 
in the eastern shore of Maryland and Virginia observed 
in the 1960s was unlikely to be caused by transmission 
vectored by the two competent species identified in this 
study [8]. A more plausible explanation might be the 
involvement of other vectors known for zoonotic trans-
mission of arboviruses including Ae. sollicitans and Ae. 
taeniorhynchus.
As an invasive species, the increasing infestation of Ae. 
albopictus, and its high competence for CVV, also raised 
an interesting question: whether or not the introduction 
and potential spread of this species will change the epi-
demiology of CVV and other agriculturally important 
arboviruses in different regions of the Americas [29]? 
Increased autochthonous transmission of various human 
and zoonotic arboviruses vectored by Ae. albopictus 
has established its importance as a species that impacts 
human public health [30]. However, much less is known 
regarding its importance with respect to animal health. It 
will be of great human and animal health importance to 
further define the role of Ae. albopictus in vectoring CVV 
among animal reservoirs and humans, especially those 
located in infested areas. The findings may be helpful in 
defining the health risk associated with CVV infection, 
which remains largely unknown.
Based on our results, Ae. aegypti is likely to have lim-
ited contribution to transmission of CVV in nature 
because of the low susceptibility demonstrated in this 
study. The use of Ae. aegypti Higgs white-eye strain, a col-
onized strain derived from the Puerto Rican RexD colony 
and selected based on the high competence of a variety 
of arboviruses including several orthobunyaviruses, fur-
ther support our conclusion [31]. Although the species 
can be competent for CVV under laboratory conditions, 
a large number of infected mosquitoes may be required 
for the intensive transmission that leads to the observed 
occurrence of a high seroprevalence rate. Entomologi-
cal surveys have demonstrated that naturally occurring 
infection from Ae. aegypti with CVV is a rare event [32]. 
Therefore, Ae. aegypti is unlikely to serve as an impor-
tant urban vector responsible for frequent human expo-
sures to CVV and its related subtypes. To the best of our 
knowledge, infestation of Ae. albopictus has not yet been 
reported in the Córodoba province, Argentina. The pop-
ulation of Ae. aegypti has been known to be involved in 
the transmission of arboviruses in the region but should 
not contribute to the transmission of CVV to humans 
[33, 34]. Collectively, available evidence suggests that 
high prevalence rates of human neutralizing antibodies 
against CVV in Latin America may involve transmission 
by other mammophillic domestic and peridomestic mos-
quito species. Identifying such species will be particularly 
important for the advancement of our knowledge for the 
ecology of CVV and other regional subtypes in selected 
regions in Latin America.
Conclusions
For the first time, our laboratory investigation suggests 
that two Aedes species known for their competence of 
important pathogenic arboviruses such as dengue and 
yellow fever viruses, are also competent for CVV. The 
differential susceptibility between Ae. albopictus and Ae. 
aegypti indicates the potential difference in the efficiency 
of vectoring CVV to humans in nature. As a highly sus-
ceptible species competent for the transmission of CVV, 
populations of Ae. albopictus, which feed on viremic 
hosts and humans, can be of significance in veterinary 
public health and the ecology of CVV and its related sub-
types in the Americas, as the infestation of Ae. albopictus 
continues to be reported in different regions.
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